Drawing for WONFREXO

USPTO serial 99750828

WONFREXO

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
ELLINGER FATHY, JESSICA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WONFREXO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexandra Kochian

Alexandra Kochian Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St.,17th FLNew York, NY 10036

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, inflammatory and immunological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the central nervous system; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, immune-mediated, inflammatory, immunological, central nervous system and neurological diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 29, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 6, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 6, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 10, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 10, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jun 10, 2026CNSLSUSPENSION LETTER WRITTEN—
Jun 9, 2026DOCKASSIGNED TO EXAMINER—
Apr 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 8, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 8, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance